Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles

Arch Pharm (Weinheim). 2008 Jan;341(1):61-5. doi: 10.1002/ardp.200700119.

Abstract

This paper describes preparation and biological evaluation of pyrazinamide analogues. Pyrazinamide with its simple structure gives a good opportunity for further modification regarding an increase of its antimycobacterial activity. We prepared a series of compounds derived from pyrazine-2,5-dicarbonitrile with arylamino substitution in position 3. All compounds were assayed in vitro against major Mycobacterium and various Fungi species. The best activity was found in 3-{[3-(trifluoromethyl)phenyl]amino}pyrazine-2,5-dicarbonitrile 11 with the value of 6.25 micromol(-1) against M. tuberculosis H(37)Rv and moderate activity against minor Mycobacterium pathogens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absidia / drug effects
  • Antifungal Agents / chemical synthesis*
  • Antifungal Agents / pharmacology
  • Antitubercular Agents / chemical synthesis*
  • Antitubercular Agents / pharmacology
  • Aspergillus fumigatus / drug effects
  • Candida / drug effects
  • Chromatography, High Pressure Liquid
  • Microbial Sensitivity Tests
  • Mycobacterium / drug effects
  • Nitriles / chemical synthesis*
  • Nitriles / pharmacology
  • Pyrazinamide / analogs & derivatives*
  • Pyrazinamide / chemical synthesis*
  • Pyrazinamide / pharmacology
  • Pyrazines / chemical synthesis*
  • Pyrazines / pharmacology
  • Structure-Activity Relationship
  • Trichosporon / drug effects

Substances

  • 3-((3-(trifluoromethyl)phenyl)amino)pyrazine-2,5-dicarbonitrile
  • Antifungal Agents
  • Antitubercular Agents
  • Nitriles
  • Pyrazines
  • Pyrazinamide